▲ BUY
9
/ 10
Conviction
$ Value
$77K
Shares
4,300
Price
$18
Filed
Mar 3
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Cluster: 4 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Alfonso Eduardo
Title
—
CIK
0002104484
Roles
Director
Transaction Details
Transaction Date
2026-03-02
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,555
Footnotes
Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).
Filing Info
Alfonso Eduardo's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | BLCO | ▲ | $77K ★ |
| 2026-03-02 | BLCO | A | $0 |
| 2026-02-19 | BLCO | A | $0 |
Other Insiders at BLCO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| COLLIS STEVEN H | $267K | — | 2026-02-23 |
|
SAUNDERS BRENT L
CEO and Chairman of the Board
|
$252K | — | 2026-03-06 |
|
Bailey A Robert D
EVP & Chief Legal Officer
|
$250K | — | 2026-03-06 |
| VON ESCHENBACH ANDREW C. | $80K | — | 2026-02-27 |
| Ross Thomas W. Sr. | $80K | — | 2026-03-03 |
| ROBERTSON RUSSEL C | $79K | — | 2026-02-20 |
| Ling Karen | $71K | — | 2026-02-19 |
|
Eldessouky Sam
EVP and CFO
|
$69K | — | 2026-03-06 |
| Paulson John | — | — | 2026-02-19 |
|
Munsch Frederick
SVP, Controller and CAO
|
— | — | 2026-02-27 |
|
Hashad Yehia
EVP of R&D and CMO
|
— | — | 2026-02-27 |
|
Stewart Andrew J.
President, GPIC
|
— | — | 2026-02-27 |
|
Bonnefoy Luc
President, Surgical
|
— | — | 2026-02-27 |
| Alfonso Eduardo | — | — | 2026-03-02 |